The bill to amend the Therapeutic Goods Act was referred to the Senate for enquiry in late 2017, and since has been passed with further amendments. The bill triggered outcry by stakeholders who voiced concern that some of the proposed amendments may make the already widely criticised system, even worse.
Categories
TGA Reform and Why You Should Care About It
